Jorge Ferreira

MD, Head of Inpatient Unit

Portugal

Research Interests

Explore related searches

Professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jorge Ferreira, MD, is the Head of the Inpatient Unit at Hospital Santa Cruz in Portugal. His research areas encompass cardiometabolic diseases, heart failure management, and the efficacy of anticoagulants in cardiovascular treatments. Dr. Ferreira has contributed to multiple recent publications addressing topics such as triglyceride-rich lipoprotein therapies, atherosclerosis, and advanced strategies for heart failure care. His work reflects a commitment to improving patient outcomes through innovative healthcare approaches.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (21)

Jose Silva-Cardoso

Professor Catedrático

Universidade do Porto Faculdade de Medicina

PORTUGAL

Jorge Ferreira

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Glucosylated cholesterol accumulates in atherosclerotic lesions and impacts macrophage immune response

Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction – Part I: Pathophysiology, diagnosis and treatment

A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction – Part II: Unmet needs and organization of care in Portugal

Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease

The Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin for Left Ventricular Thrombus Resolution.

Multidisciplinary cardiorenal program for heart failure patients: Improving outcomes through comprehensive care.

Thromboprophylaxis and adult congenital heart disease: The latest on indications, risk scoring and therapy.

Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction

Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry

European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics

Outcomes of ventricular tachycardia ablation in patients with ischemic and non-ischemic cardiomyopathy: A propensity-score matched analysis.

Attainment of LDL-Cholesterol Goals in Patients with Previous Myocardial Infarction: A Real-World Cross-Sectional Analysis.

Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy.

Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease.

Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials.

TOGETHER we can overcome barriers for optimal management of heart failure.

Impact of pulmonary vein isolation on atrial arrhythmias in patients with typical atrial flutter: systematic review and meta-analysis of randomized clinical trials.

Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study

Collaborators (21)

Jose Silva-Cardoso

Irina Kislaya

Mario Santos

Jolanta Maria Siller-Matula

Victor Aboyans

jan cornel

Adalberto Campos Fernandes

Inês Ferreira

Otilia Vieira

Maria Soares

JAVIER BOTAS

Marta Artola

Quélia Ribeiro

Paulo Santos

Michal Tendera

Joana Pimenta

Nick Townsend

Panos Vardas

Lígia Mendes

Maryam Kavousi

Dante Manyari

Make your next move.